| (-)-epigallocatechin 3-gallate | increases phosphorylation | ISO | RGD:733891 | 6480464 | epigallocatechin gallate results in increased phosphorylation of GSK3B protein | CTD | PMID:16968065 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:733891 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GSK3B mRNA | CTD | PMID:22079256 |
| (R)-lipoic acid | increases phosphorylation | EXP | | 6480464 | Thioctic Acid results in increased phosphorylation of GSK3B protein | CTD | PMID:19879292 |
| (S)-colchicine | decreases expression | ISO | RGD:70982 | 6480464 | Colchicine results in decreased expression of GSK3B mRNA | CTD | PMID:18255150 |
| (S)-nicotine | multiple interactions | ISO | RGD:733891 | 6480464 | [Nicotine results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3B protein | CTD | PMID:12511591 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:733891 | 6480464 | Dinitrochlorobenzene results in increased expression of GSK3B mRNA | CTD | PMID:17374397 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:70982 | 6480464 | Ethinyl Estradiol results in increased expression of GSK3B mRNA | CTD | PMID:12655037 PMID:15576828 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:70982 | 6480464 | Ethinyl Estradiol results in increased expression of GSK3B mRNA | CTD | PMID:15576828 PMID:12655037 |
| 17beta-estradiol | increases phosphorylation | ISO | RGD:733891 | 6480464 | Estradiol results in increased phosphorylation of GSK3B protein | CTD | PMID:16076840 |
| 17beta-estradiol | affects expression | ISO | RGD:733891 | 6480464 | Estradiol affects the expression of GSK3B mRNA | CTD | PMID:22574217 |
| 17beta-estradiol | multiple interactions | ISO | RGD:70982 | 6480464 | Estradiol inhibits the reaction [Progesterone results in decreased expression of GSK3B mRNA] | CTD | PMID:17170212 |
| 17beta-estradiol | increases phosphorylation | EXP | | 6480464 | Estradiol results in increased phosphorylation of GSK3B protein | CTD | PMID:15845746 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein]; more ... | CTD | PMID:15845746 |
| 17beta-estradiol | multiple interactions | ISO | RGD:733891 | 6480464 | wortmannin inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein] | CTD | PMID:16076840 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | decreases phosphorylation | ISO | RGD:733891 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased phosphorylation of GSK3B protein | CTD | PMID:20394812 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733891 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GSK3B mRNA | CTD | PMID:11007951 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSK3B mRNA | CTD | PMID:15034205 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of GSK3B mRNA] | CTD | PMID:15034205 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases phosphorylation | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased phosphorylation of GSK3B protein | CTD | PMID:18996433 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:733891 | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of GSK3B mRNA] | CTD | PMID:11007951 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:70982 | 6480464 | 2,6-dinitrotoluene affects the expression of GSK3B mRNA | CTD | PMID:21346803 |
| 2-methylcholine | affects expression | ISO | RGD:733891 | 6480464 | beta-methylcholine affects the expression of GSK3B mRNA | CTD | PMID:21179406 |
| 2-nitrotoluene | affects expression | ISO | RGD:70982 | 6480464 | 2-nitrotoluene affects the expression of GSK3B mRNA | CTD | PMID:16460773 |
| 3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | GSK3B protein affects the reaction [Deamino Arginine Vasopressin results in increased abundance of Cyclic AMP] | CTD | PMID:20056751 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | ISO | RGD:70982 | 6480464 | bredinin inhibits the reaction [Puromycin Aminonucleoside results in increased phosphorylation of GSK3B protein] | CTD | PMID:20502051 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases phosphorylation | ISO | RGD:70982 | 6480464 | Puromycin Aminonucleoside results in increased phosphorylation of GSK3B protein | CTD | PMID:20502051 |
| 3,3'-diindolylmethane | decreases phosphorylation | ISO | RGD:733891 | 6480464 | 3,3'-diindolylmethane results in decreased phosphorylation of GSK3B protein | CTD | PMID:22290291 |
| 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GSK3B protein; more ... | CTD | PMID:19285098 |
| 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GSK3B mRNA | CTD | PMID:19285098 PMID:20188158 |
| 3alpha-hydroxy-5beta-pregnan-20-one | decreases expression | ISO | RGD:70982 | 6480464 | Pregnanolone results in decreased expression of GSK3B protein | CTD | PMID:17443805 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | RGD:733891 | 6480464 | [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3B protein | CTD | PMID:12511591 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:733891 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of GSK3B mRNA | CTD | PMID:12419474 |
| 4-vinylcyclohexene dioxide | affects expression | EXP | | 6480464 | 4-vinyl-1-cyclohexene dioxide affects the expression of GSK3B mRNA | CTD | PMID:20829426 |
| 5alpha-pregnane-3,20-dione | decreases expression | ISO | RGD:70982 | 6480464 | 5-alpha-Dihydroprogesterone results in decreased expression of GSK3B protein | CTD | PMID:17443805 |
| acetylsalicylic acid | decreases phosphorylation | ISO | RGD:733891 | 6480464 | Aspirin results in decreased phosphorylation of GSK3B protein | CTD | PMID:11593435 |
| acetylsalicylic acid | increases phosphorylation | ISO | RGD:70982 | 6480464 | Aspirin results in increased phosphorylation of GSK3B protein | CTD | PMID:12813129 |
| acetylsalicylic acid | decreases activity | ISO | RGD:733891 | 6480464 | Aspirin results in decreased activity of GSK3B protein | CTD | PMID:19966835 |
| alachlor | multiple interactions | EXP | | 6480464 | [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein | CTD | PMID:19883720 |
| all-trans-retinoic acid | decreases phosphorylation | EXP | | 6480464 | Tretinoin results in decreased phosphorylation of GSK3B protein | CTD | PMID:16288212 |
| all-trans-retinoic acid | affects expression | ISO | RGD:733891 | 6480464 | Tretinoin affects the expression of GSK3B mRNA | CTD | PMID:15498508 |
| all-trans-retinoic acid | increases phosphorylation | EXP | | 6480464 | Tretinoin results in increased phosphorylation of GSK3B protein | CTD | PMID:16288212 |
| ammonium chloride | affects expression | ISO | RGD:70982 | 6480464 | Ammonium Chloride affects the expression of GSK3B mRNA | CTD | PMID:16483693 |
| amphetamine | increases response to substance | EXP | | 6480464 | GSK3B gene mutant form results in increased susceptibility to Amphetamine | CTD | PMID:20357757 |
| amphetamine | decreases expression | ISO | RGD:70982 | 6480464 | Amphetamine results in decreased expression of GSK3B protein | CTD | PMID:16144542 |
| arachidonic acid | multiple interactions | ISO | RGD:733891 | 6480464 | [SB 216763 results in decreased activity of GSK3B protein] results in decreased susceptibility to [Arachidonic Acid co-treated with Iron] | CTD | PMID:19620254 |
| arsenic atom | increases phosphorylation | EXP | | 6480464 | Arsenic results in increased phosphorylation of GSK3B protein | CTD | PMID:22552367 |
| arsenic atom | increases phosphorylation | ISO | RGD:733891 | 6480464 | Arsenic results in increased phosphorylation of GSK3B protein | CTD | PMID:22552367 |
| arsenite(3-) | increases expression | ISO | RGD:733891 | 6480464 | arsenite metabolite results in increased expression of GSK3B mRNA | CTD | PMID:18242949 |
| baicalein | decreases phosphorylation | ISO | RGD:733891 | 6480464 | baicalein results in decreased phosphorylation of GSK3B protein | CTD | PMID:22820424 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of GSK3B mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of GSK3B mRNA | CTD | PMID:15034205 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of GSK3B mRNA] | CTD | PMID:15034205 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70982 | 6480464 | GSK3B protein affects the reaction [Benzo(a)pyrene results in increased expression of HK2 mRNA] | CTD | PMID:22100782 |
| bleomycin A2 | multiple interactions | ISO | RGD:733891 | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein] which results in decreased susceptibility to Bleomycin; more ... | CTD | PMID:19429264 |
| bleomycin A2 | increases phosphorylation | ISO | RGD:733891 | 6480464 | Bleomycin results in increased phosphorylation of GSK3B protein | CTD | PMID:19429264 |
| bromochloroacetic acid | affects expression | ISO | RGD:70982 | 6480464 | bromochloroacetic acid affects the expression of GSK3B mRNA | CTD | PMID:16460773 |
| cadmium atom | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | CTD | PMID:19126599 |
| cadmium atom | increases response to substance | EXP | | 6480464 | GSK3B protein results in increased susceptibility to Cadmium | CTD | PMID:19126599 |
| cadmium atom | increases phosphorylation | EXP | | 6480464 | Cadmium results in increased phosphorylation of GSK3B protein | CTD | PMID:19126599 |
| caffeine | increases phosphorylation | ISO | RGD:733891 | 6480464 | Caffeine results in increased phosphorylation of GSK3B protein | CTD | PMID:21229324 |
| caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of GSK3B protein | CTD | PMID:15126379 |
| caffeine | multiple interactions | ISO | RGD:733891 | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Caffeine results in increased phosphorylation of GSK3B protein] | CTD | PMID:21229324 |
| capsaicin | multiple interactions | ISO | RGD:733891 | 6480464 | GSK3B mutant form inhibits the reaction [Capsaicin results in increased expression of GDF15 mRNA]; more ... | CTD | PMID:20110283 |
| carbon monoxide | multiple interactions | EXP | | 6480464 | Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of GSK3B protein] | CTD | PMID:18037988 |
| carbon monoxide | increases phosphorylation | EXP | | 6480464 | Carbon Monoxide results in increased phosphorylation of GSK3B protein | CTD | PMID:18845810 |
| celecoxib | decreases phosphorylation | ISO | RGD:733891 | 6480464 | celecoxib results in decreased phosphorylation of GSK3B protein | CTD | PMID:17257745 |
| celecoxib | multiple interactions | ISO | RGD:733891 | 6480464 | GSK3B mutant form inhibits the reaction [celecoxib results in increased expression of GDF15] | CTD | PMID:17257745 |
| chlorpyrifos | decreases expression | ISO | RGD:70982 | 6480464 | Chlorpyrifos results in decreased expression of GSK3B mRNA | CTD | PMID:18668222 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GSK3B gene | CTD | PMID:20938992 |
| chromium(6+) | increases phosphorylation | EXP | | 6480464 | chromium hexavalent ion results in increased phosphorylation of GSK3B protein | CTD | PMID:22552367 |
| cisplatin | multiple interactions | ISO | RGD:733891 | 6480464 | GSK3B mutant form inhibits the reaction [Cisplatin results in increased expression of LGALS3 protein] | CTD | PMID:21821001 |
| cisplatin | decreases phosphorylation | ISO | RGD:733891 | 6480464 | Cisplatin results in decreased phosphorylation of GSK3B protein | CTD | PMID:21603599 PMID:21821001 |
| cisplatin | decreases phosphorylation | ISO | RGD:733891 | 6480464 | Cisplatin results in decreased phosphorylation of GSK3B protein | CTD | PMID:21821001 PMID:21603599 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of GSK3B mRNA | CTD | PMID:21151649 |
| clozapine | increases phosphorylation | ISO | RGD:733891 | 6480464 | Clozapine results in increased phosphorylation of GSK3B protein | CTD | PMID:19440698 |
| clozapine | increases expression | ISO | RGD:70982 | 6480464 | Clozapine results in increased expression of GSK3B protein | CTD | PMID:16144542 PMID:19359144 |
| clozapine | increases expression | ISO | RGD:70982 | 6480464 | Clozapine results in increased expression of GSK3B protein | CTD | PMID:19359144 PMID:16144542 |
| clozapine | multiple interactions | ISO | RGD:70982 | 6480464 | DRD2 protein affects the reaction [Clozapine results in increased expression of GSK3B protein] | CTD | PMID:16144542 |
| cocaine | multiple interactions | EXP | | 6480464 | Cocaine results in decreased phosphorylation of and results in increased activity of GSK3B protein | CTD | PMID:19328817 |
| cocaine | increases activity | EXP | | 6480464 | Cocaine results in increased activity of GSK3B protein | CTD | PMID:19328817 |
| coenzyme Q10 | multiple interactions | ISO | RGD:70982 | 6480464 | coenzyme Q10 inhibits the reaction [APP protein results in decreased phosphorylation of GSK3B protein] | CTD | PMID:22186599 |
| copper atom | multiple interactions | ISO | RGD:733891 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of GSK3B mRNA | CTD | PMID:20971185 |
| copper atom | multiple interactions | ISO | RGD:733891 | 6480464 | [Copper binds to Thiosemicarbazones analog] which results in decreased activity of GSK3B protein | CTD | PMID:19122148 |
| copper atom | multiple interactions | ISO | RGD:733891 | 6480464 | [Thiosemicarbazones binds to Copper] which results in increased expression of GSK3B protein | CTD | PMID:20931265 |
| copper(0) | multiple interactions | ISO | RGD:733891 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of GSK3B mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:733891 | 6480464 | [Copper binds to Thiosemicarbazones analog] which results in decreased activity of GSK3B protein | CTD | PMID:19122148 |
| copper(0) | multiple interactions | ISO | RGD:733891 | 6480464 | [Thiosemicarbazones binds to Copper] which results in increased expression of GSK3B protein | CTD | PMID:20931265 |
| copper(2+) sulfate | increases expression | ISO | RGD:733891 | 6480464 | Copper Sulfate results in increased expression of GSK3B mRNA | CTD | PMID:19549813 |
| curcumin | decreases phosphorylation | ISO | RGD:733891 | 6480464 | Curcumin results in decreased phosphorylation of GSK3B protein | CTD | PMID:18790744 |
| curcumin | decreases phosphorylation | EXP | | 6480464 | Curcumin results in decreased phosphorylation of GSK3B protein | CTD | PMID:18006147 |
| curcumin | increases expression | ISO | RGD:733891 | 6480464 | Curcumin results in increased expression of GSK3B protein | CTD | PMID:19573523 |
| cycloheximide | multiple interactions | ISO | RGD:733891 | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of GSK3B mRNA] | CTD | PMID:11007951 |
| cyclosporin A | decreases expression | ISO | RGD:733891 | 6480464 | Cyclosporine results in decreased expression of GSK3B mRNA | CTD | PMID:22147139 |
| cyclosporin A | increases phosphorylation | EXP | | 6480464 | Cyclosporine results in increased phosphorylation of GSK3B protein | CTD | PMID:22416070 |
| cyclosporin A | increases phosphorylation | ISO | RGD:733891 | 6480464 | Cyclosporine results in increased phosphorylation of GSK3B protein | CTD | PMID:22416070 |
| cyclosporin A | multiple interactions | ISO | RGD:733891 | 6480464 | [GSK3A protein co-treated with GSK3B protein] affects the reaction [Cyclosporine results in increased expression of SNAI1 protein] | CTD | PMID:22416070 |
| D-glucose | multiple interactions | ISO | RGD:70982 | 6480464 | Glucose results in decreased phosphorylation of and results in increased activity of GSK3B protein; more ... | CTD | PMID:18004065 |
| D-glucose | multiple interactions | EXP | | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose] | CTD | PMID:22180358 |
| D-glucose | multiple interactions | ISO | RGD:733891 | 6480464 | [[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose | CTD | PMID:22062806 |
| desmopressin | multiple interactions | EXP | | 6480464 | GSK3B protein affects the reaction [Deamino Arginine Vasopressin results in increased abundance of Cyclic AMP] | CTD | PMID:20056751 |
| diarsenic trioxide | increases phosphorylation | ISO | RGD:733891 | 6480464 | arsenic trioxide results in increased phosphorylation of GSK3B protein | CTD | PMID:21278055 |
| diarsenic trioxide | increases expression | ISO | RGD:733891 | 6480464 | arsenic trioxide results in increased expression of GSK3B mRNA | CTD | PMID:22521957 |
| diarsenic trioxide | multiple interactions | ISO | RGD:733891 | 6480464 | GSK3B protein modified form affects the reaction [arsenic trioxide results in increased expression of CDKN1A protein]; more ... | CTD | PMID:21278055 |
| diarsenic trioxide | affects response to substance | ISO | RGD:733891 | 6480464 | GSK3B protein affects the susceptibility to arsenic trioxide | CTD | PMID:21278055 |
| diazinon | multiple interactions | EXP | | 6480464 | [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein | CTD | PMID:19883720 |
| diazoxide | multiple interactions | ISO | RGD:70982 | 6480464 | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in decreased phosphorylation of GSK3B protein]; more ... | CTD | PMID:18806606 |
| diazoxide | increases phosphorylation | ISO | RGD:70982 | 6480464 | Isoproterenol results in increased phosphorylation of GSK3B protein | CTD | PMID:16716347 PMID:15951400 |
| diazoxide | increases phosphorylation | ISO | RGD:70982 | 6480464 | Isoproterenol results in increased phosphorylation of GSK3B protein | CTD | PMID:15951400 PMID:16716347 |
| diazoxide | decreases phosphorylation | ISO | RGD:70982 | 6480464 | Isoproterenol results in decreased phosphorylation of GSK3B protein | CTD | PMID:18806606 |
| diazoxide | multiple interactions | ISO | RGD:70982 | 6480464 | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one promotes the reaction [Isoproterenol results in increased phosphorylation of GSK3B protein] | CTD | PMID:15951400 |
| diazoxide | multiple interactions | ISO | RGD:70982 | 6480464 | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in increased phosphorylation of GSK3B protein] | CTD | PMID:16716347 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of GSK3B mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | multiple interactions | ISO | RGD:733891 | 6480464 | HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate results in increased phosphorylation of GSK3B protein] | CTD | PMID:22552774 |
| dibutyl phthalate | increases phosphorylation | ISO | RGD:733891 | 6480464 | Dibutyl Phthalate results in increased phosphorylation of GSK3B protein | CTD | PMID:22552774 |
| disodium selenite | decreases expression | ISO | RGD:733891 | 6480464 | Sodium Selenite results in decreased expression of GSK3B mRNA | CTD | PMID:18175754 |
| dobutamine | affects response to substance | EXP | | 6480464 | GSK3B gene mutant form affects the susceptibility to Dobutamine | CTD | PMID:17901358 |
| doxorubicin | increases phosphorylation | ISO | RGD:733891 | 6480464 | Doxorubicin results in increased phosphorylation of GSK3B protein | CTD | PMID:17339365 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of GSK3B protein] | CTD | PMID:18037988 |
| doxorubicin | decreases phosphorylation | EXP | | 6480464 | Doxorubicin results in decreased phosphorylation of GSK3B protein | CTD | PMID:18037988 |
| doxorubicin | multiple interactions | ISO | RGD:733891 | 6480464 | methylselenic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of GSK3B protein]; more ... | CTD | PMID:17339365 |
| elemental selenium | multiple interactions | ISO | RGD:733891 | 6480464 | Selenium inhibits the reaction [Doxorubicin results in increased phosphorylation of GSK3B protein] | CTD | PMID:17339365 |
| elemental selenium | decreases phosphorylation | ISO | RGD:733891 | 6480464 | Selenium results in decreased phosphorylation of GSK3B protein | CTD | PMID:17339365 |
| elemental selenium | multiple interactions | ISO | RGD:733891 | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of GSK3B mRNA | CTD | PMID:19244175 |
| elemental selenium | decreases expression | ISO | RGD:733891 | 6480464 | Selenium results in decreased expression of GSK3B mRNA | CTD | PMID:19244175 |
| enalapril | multiple interactions | ISO | RGD:70982 | 6480464 | Enalapril inhibits the reaction [Isoproterenol results in decreased phosphorylation of GSK3B protein] | CTD | PMID:18806606 |
| endosulfan | multiple interactions | EXP | | 6480464 | [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein | CTD | PMID:19883720 |
| ethanol | decreases phosphorylation | EXP | | 6480464 | Ethanol results in decreased phosphorylation of GSK3B protein | CTD | PMID:18377926 |
| ethanol | multiple interactions | ISO | RGD:733891 | 6480464 | [sodium arsenite co-treated with Ethanol] results in increased phosphorylation of GSK3B protein | CTD | PMID:22872060 |
| ethanol | increases phosphorylation | EXP | | 6480464 | Ethanol results in increased phosphorylation of GSK3B protein | CTD | PMID:19332462 PMID:22459179 |
| ethanol | decreases phosphorylation | EXP | | 6480464 | Ethanol results in decreased phosphorylation of GSK3B protein | CTD | PMID:18377926 PMID:19429258 |
| ethanol | multiple interactions | ISO | RGD:733891 | 6480464 | ALDH2 protein inhibits the reaction [Ethanol results in decreased phosphorylation of GSK3B protein] | CTD | PMID:19429258 |
| ethanol | increases phosphorylation | EXP | | 6480464 | Ethanol results in increased phosphorylation of GSK3B protein | CTD | PMID:19332462 |
| ethanol | multiple interactions | EXP | | 6480464 | ALDH2 protein inhibits the reaction [Ethanol results in increased phosphorylation of GSK3B protein] | CTD | PMID:19332462 |
| etoposide | multiple interactions | EXP | | 6480464 | BCL2 protein affects the reaction [[Etoposide results in increased activity of GSK3B protein] which results in increased activity of CASP3 protein] | CTD | PMID:19408126 |
| etoposide | increases activity | EXP | | 6480464 | Etoposide results in increased activity of GSK3B protein; more ... | CTD | PMID:19408126 |
| eugenol | increases expression | ISO | RGD:733891 | 6480464 | Eugenol results in increased expression of GSK3B mRNA | CTD | PMID:17374397 |
| fipronil | decreases phosphorylation | ISO | RGD:733891 | 6480464 | fipronil results in decreased phosphorylation of GSK3B protein | CTD | PMID:21296133 |
| fipronil | affects response to substance | ISO | RGD:733891 | 6480464 | GSK3B protein affects the susceptibility to fipronil | CTD | PMID:21296133 |
| fipronil | multiple interactions | ISO | RGD:733891 | 6480464 | Lithium Chloride inhibits the reaction [fipronil results in decreased phosphorylation of GSK3B protein]; more ... | CTD | PMID:21296133 |
| fluoxetine | increases expression | ISO | RGD:70982 | 6480464 | Fluoxetine results in increased expression of GSK3B protein | CTD | PMID:19359144 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GSK3B gene | CTD | PMID:20938992 |
| genistein | decreases phosphorylation | ISO | RGD:733891 | 6480464 | Genistein results in decreased phosphorylation of GSK3B protein | CTD | PMID:18431742 |
| glucose | multiple interactions | ISO | RGD:70982 | 6480464 | Glucose results in decreased phosphorylation of and results in increased activity of GSK3B protein; more ... | CTD | PMID:18004065 |
| glucose | multiple interactions | EXP | | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose] | CTD | PMID:22180358 |
| glucose | multiple interactions | ISO | RGD:733891 | 6480464 | [[ginsenoside Rg2 results in increased phosphorylation of GSK3B protein] co-treated with [ginsenoside Rg2 results in increased expression of NR0B2 mRNA]] results in decreased chemical synthesis of Glucose | CTD | PMID:22062806 |
| haloperidol | multiple interactions | ISO | RGD:70982 | 6480464 | DRD2 protein affects the reaction [Haloperidol results in increased expression of GSK3B protein] | CTD | PMID:16144542 |
| haloperidol | increases expression | ISO | RGD:70982 | 6480464 | Haloperidol results in increased expression of GSK3B protein | CTD | PMID:19359144 PMID:16144542 |
| haloperidol | increases expression | ISO | RGD:70982 | 6480464 | Haloperidol results in increased expression of GSK3B mRNA | CTD | PMID:19359144 |
| haloperidol | increases expression | ISO | RGD:70982 | 6480464 | Haloperidol results in increased expression of GSK3B protein | CTD | PMID:16144542 PMID:19359144 |
| heptadecafluorononanoic acid | increases expression | ISO | RGD:70982 | 6480464 | perfluoro-n-nonanoic acid results in increased expression of GSK3B protein modified form | CTD | PMID:22387981 |
| hexachlorobenzene | decreases activity | ISO | RGD:70982 | 6480464 | Hexachlorobenzene results in decreased activity of GSK3B protein | CTD | PMID:16679308 |
| hexachlorobenzene | multiple interactions | ISO | RGD:70982 | 6480464 | [Hexachlorobenzene results in decreased activity of GSK3B protein] which results in decreased expression of CDH1 protein | CTD | PMID:16679308 |
| hydrogen peroxide | increases phosphorylation | ISO | RGD:733891 | 6480464 | Hydrogen Peroxide results in increased phosphorylation of GSK3B protein | CTD | PMID:20302854 |
| hydrogen peroxide | affects expression | ISO | RGD:733891 | 6480464 | Hydrogen Peroxide affects the expression of GSK3B mRNA | CTD | PMID:21179406 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | [[Hydrogen Peroxide results in increased phosphorylation of GSK3B protein] which affects the localization of FYN protein] which affects the localization of NFE2L2 protein; more ... | CTD | PMID:21690096 |
| hydrogen peroxide | multiple interactions | ISO | RGD:733891 | 6480464 | Mycophenolic Acid inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of GSK3B protein] | CTD | PMID:20302854 |
| indomethacin | increases expression | ISO | RGD:70982 | 6480464 | Indomethacin results in increased expression of GSK3B mRNA | CTD | PMID:18299717 |
| iron atom | multiple interactions | ISO | RGD:733891 | 6480464 | [SB 216763 results in decreased activity of GSK3B protein] results in decreased susceptibility to [Arachidonic Acid co-treated with Iron] | CTD | PMID:19620254 |
| isoprenaline | multiple interactions | ISO | RGD:70982 | 6480464 | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in decreased phosphorylation of GSK3B protein]; more ... | CTD | PMID:18806606 |
| isoprenaline | increases phosphorylation | ISO | RGD:70982 | 6480464 | Isoproterenol results in increased phosphorylation of GSK3B protein | CTD | PMID:16716347 PMID:15951400 |
| isoprenaline | increases phosphorylation | ISO | RGD:70982 | 6480464 | Isoproterenol results in increased phosphorylation of GSK3B protein | CTD | PMID:15951400 PMID:16716347 |
| isoprenaline | decreases phosphorylation | ISO | RGD:70982 | 6480464 | Isoproterenol results in decreased phosphorylation of GSK3B protein | CTD | PMID:18806606 |
| isoprenaline | multiple interactions | ISO | RGD:70982 | 6480464 | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in increased phosphorylation of GSK3B protein] | CTD | PMID:16716347 |
| isoprenaline | multiple interactions | ISO | RGD:70982 | 6480464 | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one promotes the reaction [Isoproterenol results in increased phosphorylation of GSK3B protein] | CTD | PMID:15951400 |
| kainic acid | decreases activity | EXP | | 6480464 | Kainic Acid results in decreased activity of GSK3B protein | CTD | PMID:18619545 |
| ketamine | decreases phosphorylation | ISO | RGD:70982 | 6480464 | Ketamine results in decreased phosphorylation of GSK3B protein | CTD | PMID:17952604 |
| L-ascorbic acid | decreases expression | ISO | RGD:70982 | 6480464 | Ascorbic Acid results in decreased expression of GSK3B mRNA | CTD | PMID:15372504 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GSK3B gene | CTD | PMID:20938992 |
| lipoic acid | increases phosphorylation | EXP | | 6480464 | Thioctic Acid results in increased phosphorylation of GSK3B protein | CTD | PMID:19879292 |
| lithium atom | multiple interactions | ISO | RGD:733891 | 6480464 | Lithium inhibits the reaction [GSK3B protein binds to TP53 protein] | CTD | PMID:15475000 |
| lithium atom | multiple interactions | ISO | RGD:733891 | 6480464 | Lithium promotes the reaction [sodium arsenite results in increased phosphorylation of GSK3B protein] | CTD | PMID:17849503 |
| lithium atom | multiple interactions | ISO | RGD:70982 | 6480464 | Lithium results in increased phosphorylation of and results in decreased activity of GSK3B protein | CTD | PMID:21711903 PMID:15950778 |
| lithium atom | increases expression | ISO | RGD:70982 | 6480464 | Lithium results in increased expression of GSK3B protein | CTD | PMID:18296634 PMID:19359144 |
| lithium atom | increases phosphorylation | ISO | RGD:733891 | 6480464 | Lithium results in increased phosphorylation of GSK3B protein | CTD | PMID:19440698 PMID:15475000 |
| lithium atom | multiple interactions | ISO | RGD:70982 | 6480464 | Lithium results in increased phosphorylation of and results in decreased activity of GSK3B protein | CTD | PMID:15950778 PMID:21711903 |
| lithium atom | increases phosphorylation | ISO | RGD:70982 | 6480464 | Lithium results in increased phosphorylation of GSK3B protein | CTD | PMID:18296634 |
| lithium atom | decreases activity | ISO | RGD:70982 | 6480464 | Lithium results in decreased activity of GSK3B protein | CTD | PMID:16288908 |
| lithium atom | increases expression | ISO | RGD:70982 | 6480464 | Lithium results in increased expression of GSK3B protein | CTD | PMID:19359144 PMID:18296634 |
| lithium atom | increases expression | ISO | RGD:70982 | 6480464 | Lithium results in increased expression of GSK3B mRNA | CTD | PMID:19359144 |
| lithium atom | multiple interactions | EXP | | 6480464 | Lithium results in increased phosphorylation of and results in decreased activity of GSK3B protein | CTD | PMID:19328817 |
| lithium atom | multiple interactions | EXP | | 6480464 | [Lithium results in decreased activity of GSK3B protein] which results in increased activity of NFE2L2 protein | CTD | PMID:18619545 |
| lithium atom | increases phosphorylation | ISO | RGD:733891 | 6480464 | Lithium results in increased phosphorylation of GSK3B protein | CTD | PMID:15475000 PMID:19440698 |
| lithium atom | multiple interactions | EXP | | 6480464 | [Lithium results in decreased activity of GSK3B protein] which results in increased activity of MTOR protein | CTD | PMID:17921520 |
| lithium atom | decreases activity | EXP | | 6480464 | Lithium results in decreased activity of GSK3B protein | CTD | PMID:19621015 |
| lithium chloride | multiple interactions | ISO | RGD:70982 | 6480464 | calyculin A promotes the reaction [Lithium Chloride results in increased phosphorylation of GSK3B protein]; more ... | CTD | PMID:12813129 |
| lithium chloride | increases phosphorylation | ISO | RGD:733891 | 6480464 | Lithium Chloride results in increased phosphorylation of GSK3B protein | CTD | PMID:18830594 more ... |
| lithium chloride | multiple interactions | ISO | RGD:733891 | 6480464 | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of HSPA1A protein alternative form | CTD | PMID:20090934 |
| lithium chloride | decreases activity | EXP | | 6480464 | Lithium Chloride results in decreased activity of GSK3B protein | CTD | PMID:15364539 more ... |
| lithium chloride | multiple interactions | ISO | RGD:733891 | 6480464 | Lithium Chloride results in decreased activity of and results in increased phosphorylation of GSK3B protein; more ... | CTD | PMID:22493441 |
| lithium chloride | decreases activity | ISO | RGD:733891 | 6480464 | Lithium Chloride results in decreased activity of GSK3B protein | CTD | PMID:19101580 more ... |
| lithium chloride | multiple interactions | ISO | RGD:733891 | 6480464 | Lithium Chloride inhibits the reaction [fipronil results in decreased phosphorylation of GSK3B protein] | CTD | PMID:21296133 |
| lithium chloride | multiple interactions | EXP | | 6480464 | [[Lithium Chloride results in decreased activity of GSK3B protein] which affects the localization of FYN protein] which affects the localization of NFE2L2 protein; more ... | CTD | PMID:21690096 |
| lithium chloride | decreases activity | ISO | RGD:733891 | 6480464 | Lithium Chloride results in decreased activity of GSK3B protein | CTD | PMID:19274078 more ... |
| lithium chloride | multiple interactions | EXP | | 6480464 | Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein | CTD | PMID:19440036 PMID:19582394 |
| lithium chloride | decreases activity | EXP | | 6480464 | Lithium Chloride results in decreased activity of GSK3B protein | CTD | PMID:19442631 more ... |
| lithium chloride | decreases activity | ISO | RGD:733891 | 6480464 | Lithium Chloride results in decreased activity of GSK3B protein | CTD | PMID:19274078 more ... |
| lithium chloride | decreases activity | ISO | RGD:70982 | 6480464 | Lithium Chloride results in decreased activity of GSK3B protein | CTD | PMID:15247282 PMID:18972237 |
| lithium chloride | decreases activity | EXP | | 6480464 | Lithium Chloride results in decreased activity of GSK3B protein | CTD | PMID:19442631 more ... |
| lithium chloride | decreases activity | ISO | RGD:733891 | 6480464 | Lithium Chloride results in decreased activity of GSK3B protein | CTD | PMID:19101580 more ... |
| lithium chloride | decreases activity | EXP | | 6480464 | Lithium Chloride results in decreased activity of GSK3B protein | CTD | PMID:15585669 more ... |
| lithium chloride | increases phosphorylation | ISO | RGD:733891 | 6480464 | Lithium Chloride results in increased phosphorylation of GSK3B protein | CTD | PMID:18830594 PMID:21278055 |
| lithium chloride | multiple interactions | ISO | RGD:733891 | 6480464 | Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein | CTD | PMID:19679347 PMID:17868649 |
| lithium chloride | increases stability | EXP | | 6480464 | Lithium Chloride results in increased stability of GSK3B protein | CTD | PMID:19448134 |
| lithium chloride | affects phosphorylation | ISO | RGD:70982 | 6480464 | Lithium Chloride affects the phosphorylation of GSK3B protein | CTD | PMID:21364661 |
| lithium chloride | multiple interactions | EXP | | 6480464 | [Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased localization of CTNNB1 protein; more ... | CTD | PMID:19582394 |
| lithium chloride | multiple interactions | EXP | | 6480464 | [Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in decreased expression of SNAI1 protein | CTD | PMID:19440036 |
| lithium chloride | multiple interactions | EXP | | 6480464 | Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein | CTD | PMID:19582394 PMID:19440036 |
| lithium chloride | multiple interactions | EXP | | 6480464 | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of AHR mRNA; more ... | CTD | PMID:21498875 |
| lithium chloride | decreases activity | EXP | | 6480464 | Lithium Chloride results in decreased activity of GSK3B protein | CTD | PMID:15364539 more ... |
| lithium chloride | increases phosphorylation | ISO | RGD:733891 | 6480464 | Lithium Chloride results in increased phosphorylation of GSK3B protein | CTD | PMID:21278055 PMID:18830594 |
| lithium chloride | multiple interactions | ISO | RGD:733891 | 6480464 | Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein | CTD | PMID:17868649 PMID:19679347 |
| lithium chloride | multiple interactions | ISO | RGD:733891 | 6480464 | Lithium Chloride results in increased expression of and results in increased phosphorylation of and results in decreased activity of GSK3B protein; more ... | CTD | PMID:19196980 |
| lithium chloride | decreases phosphorylation | ISO | RGD:733891 | 6480464 | Lithium Chloride results in decreased phosphorylation of GSK3B protein | CTD | PMID:20093106 |
| lithium chloride | multiple interactions | ISO | RGD:733891 | 6480464 | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of STARD7 mRNA; more ... | CTD | PMID:19679347 |
| lithium chloride | multiple interactions | ISO | RGD:733891 | 6480464 | [Lithium Chloride results in decreased activity of GSK3B protein] inhibits the reaction [Sirolimus results in decreased expression of CCND1 protein] | CTD | PMID:15753396 |
| lithium chloride | decreases activity | ISO | RGD:733891 | 6480464 | Lithium Chloride results in decreased activity of GSK3B protein | CTD | PMID:19823589 more ... |
| lithium chloride | multiple interactions | ISO | RGD:733891 | 6480464 | CTNNB1 protein affects the reaction [[Lithium Chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 protein]; more ... | CTD | PMID:19274078 |
| lithium chloride | decreases expression | ISO | RGD:70982 | 6480464 | Lithium Chloride results in decreased expression of GSK3B mRNA | CTD | PMID:18932008 |
| lithium chloride | multiple interactions | ISO | RGD:70982 | 6480464 | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein; more ... | CTD | PMID:18972237 |
| lithium chloride | multiple interactions | ISO | RGD:70982 | 6480464 | [Lithium Chloride results in decreased activity of GSK3B protein] inhibits the reaction [manganese chloride results in increased phosphorylation of MAPT protein] | CTD | PMID:20937724 |
| lithium chloride | decreases activity | ISO | RGD:70982 | 6480464 | Lithium Chloride results in decreased activity of GSK3B protein | CTD | PMID:18972237 PMID:15247282 |
| lithium chloride | multiple interactions | ISO | RGD:70982 | 6480464 | Lithium Chloride inhibits the reaction [sevoflurane results in decreased phosphorylation of GSK3B protein] | CTD | PMID:20807582 |
| lovastatin | decreases phosphorylation | ISO | RGD:733891 | 6480464 | Lovastatin results in decreased phosphorylation of GSK3B protein | CTD | PMID:17234346 |
| lovastatin | increases phosphorylation | ISO | RGD:70982 | 6480464 | Lovastatin results in increased phosphorylation of GSK3B protein | CTD | PMID:19741129 |
| lupeol | affects binding | ISO | RGD:70982 | 6480464 | lupeol binds to GSK3B protein | CTD | PMID:18222664 |
| LY294002 | multiple interactions | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Zinc results in increased phosphorylation of GSK3B protein] | CTD | PMID:17513037 |
| LY294002 | multiple interactions | ISO | RGD:733891 | 6480464 | Tamoxifen promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein] | CTD | PMID:22046442 |
| LY294002 | decreases phosphorylation | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein | CTD | PMID:21821001 PMID:22046442 |
| LY294002 | multiple interactions | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein]; more ... | CTD | PMID:20696143 |
| LY294002 | multiple interactions | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of GSK3B protein] | CTD | PMID:14750165 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein] | CTD | PMID:20542495 |
| LY294002 | affects response to substance | EXP | | 6480464 | GSK3B mRNA affects the susceptibility to 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | CTD | PMID:21832246 |
| LY294002 | multiple interactions | ISO | RGD:70982 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of GSK3B protein] | CTD | PMID:20064577 |
| LY294002 | multiple interactions | ISO | RGD:70982 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EPO results in increased phosphorylation of GSK3B protein] | CTD | PMID:17952604 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein] | CTD | PMID:15845746 |
| LY294002 | decreases response to substance | ISO | RGD:733891 | 6480464 | GSK3B results in decreased susceptibility to 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | CTD | PMID:21821001 |
| LY294002 | decreases phosphorylation | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein | CTD | PMID:16179367 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EPO protein results in increased phosphorylation of and results in increased activity of GSK3B protein] | CTD | PMID:17928571 |
| LY294002 | multiple interactions | ISO | RGD:733891 | 6480464 | GSK3B mutant form inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] | CTD | PMID:21821001 |
| LY294002 | increases activity | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased activity of GSK3B protein | CTD | PMID:15753396 |
| LY294002 | decreases phosphorylation | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein | CTD | PMID:21821001 |
| LY294002 | multiple interactions | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IGF1 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of GSK3B protein]] | CTD | PMID:20064577 |
| LY294002 | multiple interactions | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in increased activity of GSK3B protein | CTD | PMID:15942663 PMID:19661225 |
| LY294002 | multiple interactions | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [DEFA1 protein results in increased phosphorylation of GSK3B protein]; more ... | CTD | PMID:19814765 |
| LY294002 | multiple interactions | ISO | RGD:733891 | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein] which results in decreased susceptibility to Bleomycin | CTD | PMID:19429264 |
| maneb | multiple interactions | EXP | | 6480464 | [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein | CTD | PMID:19883720 |
| manganese(II) chloride | increases activity | ISO | RGD:70982 | 6480464 | manganese chloride results in increased activity of GSK3B protein | CTD | PMID:20937724 |
| manganese(II) chloride | multiple interactions | ISO | RGD:70982 | 6480464 | GSK3B protein affects the reaction [manganese chloride results in increased phosphorylation of MAPT protein]; more ... | CTD | PMID:20937724 |
| manganese(II) chloride | decreases phosphorylation | ISO | RGD:70982 | 6480464 | manganese chloride results in decreased phosphorylation of GSK3B protein | CTD | PMID:20937724 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [wortmannin results in decreased expression of GSK3B protein modified form] | CTD | PMID:15842767 |
| metformin | increases phosphorylation | ISO | RGD:733891 | 6480464 | Metformin results in increased phosphorylation of GSK3B protein | CTD | PMID:21054339 |
| methapyrilene | increases expression | ISO | RGD:70982 | 6480464 | Methapyrilene results in increased expression of GSK3B mRNA | CTD | PMID:16393664 |
| methotrexate | multiple interactions | ISO | RGD:733891 | 6480464 | Methotrexate promotes the reaction [6-bromoindirubin-3'-oxime results in increased phosphorylation of GSK3B protein] | CTD | PMID:19727391 |
| methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of GSK3B mRNA | CTD | PMID:20061341 |
| microcystin-LR | increases phosphorylation | ISO | RGD:733891 | 6480464 | cyanoginosin LR results in increased phosphorylation of GSK3B protein | CTD | PMID:20421190 |
| mifepristone | multiple interactions | ISO | RGD:733891 | 6480464 | Mifepristone inhibits the reaction [Progesterone results in increased phosphorylation of GSK3B protein] | CTD | PMID:16882987 |
| monodansylcadaverine | decreases expression | ISO | RGD:733891 | 6480464 | monodansylcadaverine results in decreased expression of GSK3B protein | CTD | PMID:16170020 |
| morphine | increases expression | EXP | | 6480464 | Morphine results in increased expression of GSK3B protein modified form | CTD | PMID:20600172 |
| morphine | multiple interactions | EXP | | 6480464 | Naloxone inhibits the reaction [Morphine results in increased expression of GSK3B protein modified form] | CTD | PMID:20600172 |
| mycophenolic acid | multiple interactions | ISO | RGD:733891 | 6480464 | Mycophenolic Acid inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of GSK3B protein] | CTD | PMID:20302854 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium results in increased phosphorylation of GSK3B protein] | CTD | PMID:19126599 |
| N-methyl-4-phenylpyridinium | multiple interactions | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IGF1 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of GSK3B protein]] | CTD | PMID:20064577 |
| N-methyl-4-phenylpyridinium | increases phosphorylation | ISO | RGD:70982 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased phosphorylation of GSK3B protein | CTD | PMID:20064577 |
| N-methyl-4-phenylpyridinium | multiple interactions | ISO | RGD:70982 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of GSK3B protein] | CTD | PMID:20064577 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of GSK3B protein] | CTD | PMID:20583210 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:70982 | 6480464 | morin inhibits the reaction [Diethylnitrosamine results in increased expression of GSK3B protein modified form] | CTD | PMID:19931519 |
| N-nitrosodiethylamine | increases phosphorylation | ISO | RGD:70982 | 6480464 | Diethylnitrosamine results in increased phosphorylation of GSK3B protein | CTD | PMID:21554863 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:70982 | 6480464 | Diethylnitrosamine results in increased expression of GSK3B protein modified form | CTD | PMID:19931519 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:70982 | 6480464 | 5,7-dimethoxyflavone promotes the reaction [Diethylnitrosamine results in increased phosphorylation of GSK3B protein] | CTD | PMID:21554863 |
| N-nitrosodiethylamine | increases phosphorylation | EXP | | 6480464 | Diethylnitrosamine results in increased phosphorylation of GSK3B protein | CTD | PMID:20583210 |
| naloxone | multiple interactions | EXP | | 6480464 | Naloxone inhibits the reaction [Morphine results in increased expression of GSK3B protein modified form] | CTD | PMID:20600172 |
| nickel dichloride | multiple interactions | ISO | RGD:733891 | 6480464 | [nickel chloride results in increased phosphorylation of AKT1 protein] which results in decreased activity of and results in increased phosphorylation of GSK3B protein | CTD | PMID:21837363 |
| nickel sulfate | increases expression | ISO | RGD:733891 | 6480464 | nickel sulfate results in increased expression of GSK3B mRNA | CTD | PMID:17374397 |
| nimesulide | decreases activity | ISO | RGD:733891 | 6480464 | nimesulide results in decreased activity of GSK3B protein | CTD | PMID:16331303 |
| okadaic acid | multiple interactions | ISO | RGD:733891 | 6480464 | [5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein]; more ... | CTD | PMID:21715663 |
| okadaic acid | increases expression | ISO | RGD:733891 | 6480464 | Okadaic Acid results in increased expression of GSK3B protein; more ... | CTD | PMID:21715663 |
| olanzapine | increases phosphorylation | ISO | RGD:733891 | 6480464 | olanzapine results in increased phosphorylation of GSK3B protein | CTD | PMID:19440698 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of GSK3B protein modified form | CTD | PMID:19679878 |
| paracetamol | multiple interactions | EXP | | 6480464 | GSTM1 gene mutant form inhibits the reaction [Acetaminophen results in increased phosphorylation of GSK3B protein] | CTD | PMID:22687999 |
| paracetamol | increases phosphorylation | EXP | | 6480464 | Acetaminophen results in increased phosphorylation of GSK3B protein | CTD | PMID:22687999 |
| paracetamol | affects expression | ISO | RGD:70982 | 6480464 | Acetaminophen affects the expression of GSK3B mRNA | CTD | PMID:16701773 |
| paraquat | multiple interactions | EXP | | 6480464 | Paraquat results in increased expression of and results in increased phosphorylation of GSK3B protein | CTD | PMID:22292029 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of GSK3B mRNA | CTD | PMID:23091169 |
| phenylephrine | multiple interactions | ISO | RGD:70982 | 6480464 | SGK1 protein promotes the reaction [Phenylephrine results in increased phosphorylation of GSK3B protein] | CTD | PMID:15795328 |
| phenylephrine | increases phosphorylation | ISO | RGD:70982 | 6480464 | Phenylephrine results in increased phosphorylation of GSK3B protein | CTD | PMID:15795328 |
| phloretin | decreases activity | ISO | RGD:733891 | 6480464 | Phloretin results in decreased activity of GSK3B protein | CTD | PMID:16968061 |
| phloroglucinol | decreases phosphorylation | ISO | RGD:733891 | 6480464 | Phloroglucinol analog results in decreased phosphorylation of GSK3B protein | CTD | PMID:23178381 |
| phorbol 13-acetate 12-myristate | increases phosphorylation | ISO | RGD:70982 | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of GSK3B protein | CTD | PMID:17993264 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:70982 | 6480464 | U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of GSK3B protein] | CTD | PMID:17993264 |
| potassium atom | multiple interactions | ISO | RGD:70982 | 6480464 | Potassium results in increased phosphorylation of and results in decreased activity of GSK3B protein | CTD | PMID:15950778 |
| progesterone | multiple interactions | ISO | RGD:733891 | 6480464 | Mifepristone inhibits the reaction [Progesterone results in increased phosphorylation of GSK3B protein] | CTD | PMID:16882987 |
| progesterone | decreases expression | ISO | RGD:70982 | 6480464 | Progesterone results in decreased expression of GSK3B protein | CTD | PMID:17443805 |
| progesterone | decreases expression | ISO | RGD:70982 | 6480464 | Progesterone results in decreased expression of GSK3B mRNA | CTD | PMID:17170212 |
| progesterone | decreases phosphorylation | ISO | RGD:70982 | 6480464 | Progesterone results in decreased phosphorylation of GSK3B protein | CTD | PMID:17443805 |
| progesterone | multiple interactions | ISO | RGD:70982 | 6480464 | Estradiol inhibits the reaction [Progesterone results in decreased expression of GSK3B mRNA] | CTD | PMID:17170212 |
| progesterone | multiple interactions | EXP | | 6480464 | Progesterone inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein] | CTD | PMID:15845746 |
| progesterone | increases phosphorylation | ISO | RGD:733891 | 6480464 | Progesterone results in increased phosphorylation of GSK3B protein | CTD | PMID:16882987 |
| prostaglandin E2 | increases phosphorylation | ISO | RGD:733891 | 6480464 | Dinoprostone results in increased phosphorylation of GSK3B protein | CTD | PMID:18395713 |
| prostaglandin E2 | increases phosphorylation | EXP | | 6480464 | Dinoprostone results in increased phosphorylation of GSK3B protein | CTD | PMID:20578217 |
| pterostilbene | multiple interactions | EXP | | 6480464 | pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of GSK3B protein] | CTD | PMID:20681671 |
| pyrithione | multiple interactions | ISO | RGD:70982 | 6480464 | AKT1 protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of and results in increased activity of GSK3B protein]; more ... | CTD | PMID:17098228 |
| quercetin | decreases activity | ISO | RGD:733891 | 6480464 | Quercetin results in decreased activity of GSK3B protein | CTD | PMID:16968061 |
| quercetin | decreases expression | ISO | RGD:733891 | 6480464 | Quercetin results in decreased expression of GSK3B protein | CTD | PMID:16968065 |
| resveratrol | multiple interactions | ISO | RGD:70982 | 6480464 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [resveratrol results in increased activity of GSK3B protein]; more ... | CTD | PMID:19135050 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of GSK3B protein | CTD | PMID:19665018 |
| resveratrol | decreases activity | EXP | | 6480464 | resveratrol results in decreased activity of GSK3B protein | CTD | PMID:19665018 |
| resveratrol | multiple interactions | EXP | | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose] | CTD | PMID:22180358 |
| resveratrol | multiple interactions | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein]; more ... | CTD | PMID:20696143 |
| resveratrol | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein]; more ... | CTD | PMID:20542495 |
| resveratrol | increases phosphorylation | ISO | RGD:733891 | 6480464 | resveratrol results in increased phosphorylation of GSK3B protein | CTD | PMID:14750165 |
| resveratrol | increases activity | ISO | RGD:733891 | 6480464 | resveratrol results in increased activity of GSK3B protein | CTD | PMID:17868649 PMID:20090934 |
| resveratrol | multiple interactions | ISO | RGD:733891 | 6480464 | [resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSPA1A protein; more ... | CTD | PMID:20090934 |
| resveratrol | decreases phosphorylation | ISO | RGD:733891 | 6480464 | resveratrol results in decreased phosphorylation of GSK3B protein | CTD | PMID:14750165 PMID:20090934 |
| resveratrol | multiple interactions | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of GSK3B protein] | CTD | PMID:14750165 |
| resveratrol | decreases expression | ISO | RGD:733891 | 6480464 | resveratrol results in decreased expression of GSK3B protein modified form | CTD | PMID:20133117 PMID:20457218 |
| resveratrol | affects expression | ISO | RGD:733891 | 6480464 | resveratrol affects the expression of GSK3B protein modified form | CTD | PMID:22234583 |
| resveratrol | multiple interactions | ISO | RGD:733891 | 6480464 | ARRB2 protein affects the reaction [resveratrol results in decreased expression of GSK3B protein modified form] | CTD | PMID:20457218 |
| resveratrol | increases phosphorylation | EXP | | 6480464 | resveratrol results in increased phosphorylation of GSK3B protein | CTD | PMID:19665018 PMID:22180358 |
| resveratrol | multiple interactions | ISO | RGD:70982 | 6480464 | resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein | CTD | PMID:16860989 |
| resveratrol | increases activity | ISO | RGD:733891 | 6480464 | resveratrol results in increased activity of GSK3B protein | CTD | PMID:17868649 |
| resveratrol | decreases activity | ISO | RGD:733891 | 6480464 | resveratrol results in decreased activity of GSK3B protein | CTD | PMID:19620254 |
| resveratrol | multiple interactions | ISO | RGD:733891 | 6480464 | resveratrol inhibits the reaction [MFGE8 protein results in decreased expression of GSK3B protein modified form] | CTD | PMID:21505870 |
| resveratrol | multiple interactions | ISO | RGD:733891 | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in decreased activity of GSK3B protein]; more ... | CTD | PMID:19620254 |
| resveratrol | increases expression | ISO | RGD:733891 | 6480464 | resveratrol results in increased expression of GSK3B protein modified form | CTD | PMID:21505870 |
| resveratrol | increases phosphorylation | ISO | RGD:733891 | 6480464 | resveratrol results in increased phosphorylation of GSK3B protein | CTD | PMID:14750165 PMID:19620254 |
| riboflavin | increases phosphorylation | EXP | | 6480464 | Riboflavin results in increased phosphorylation of GSK3B protein; more ... | CTD | PMID:20688149 |
| risperidone | multiple interactions | ISO | RGD:70982 | 6480464 | DRD2 protein affects the reaction [Risperidone results in increased expression of GSK3B protein] | CTD | PMID:16144542 |
| risperidone | increases expression | ISO | RGD:70982 | 6480464 | Risperidone results in increased expression of GSK3B protein | CTD | PMID:16144542 |
| rosiglitazone | decreases activity | EXP | | 6480464 | rosiglitazone results in decreased activity of GSK3B protein | CTD | PMID:19621015 |
| rosiglitazone | increases phosphorylation | ISO | RGD:70982 | 6480464 | rosiglitazone results in increased phosphorylation of GSK3B protein | CTD | PMID:19566839 |
| rosiglitazone | multiple interactions | ISO | RGD:70982 | 6480464 | wortmannin inhibits the reaction [rosiglitazone results in increased phosphorylation of GSK3B protein] | CTD | PMID:19566839 |
| ruthenium atom | decreases activity | ISO | RGD:733891 | 6480464 | Ruthenium results in decreased activity of GSK3B protein | CTD | PMID:17210701 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases phosphorylation | EXP | | 6480464 | Buthionine Sulfoximine results in decreased phosphorylation of GSK3B protein | CTD | PMID:18552690 |
| selenium atom | multiple interactions | ISO | RGD:733891 | 6480464 | Selenium inhibits the reaction [Doxorubicin results in increased phosphorylation of GSK3B protein] | CTD | PMID:17339365 |
| selenium atom | decreases phosphorylation | ISO | RGD:733891 | 6480464 | Selenium results in decreased phosphorylation of GSK3B protein | CTD | PMID:17339365 |
| selenium atom | multiple interactions | ISO | RGD:733891 | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of GSK3B mRNA | CTD | PMID:19244175 |
| selenium atom | decreases expression | ISO | RGD:733891 | 6480464 | Selenium results in decreased expression of GSK3B mRNA | CTD | PMID:19244175 |
| serotonin | increases phosphorylation | ISO | RGD:733891 | 6480464 | Serotonin results in increased phosphorylation of GSK3B protein | CTD | PMID:20190034 |
| sevoflurane | multiple interactions | ISO | RGD:70982 | 6480464 | Lithium Chloride inhibits the reaction [sevoflurane results in decreased phosphorylation of GSK3B protein] | CTD | PMID:20807582 |
| sevoflurane | decreases phosphorylation | ISO | RGD:70982 | 6480464 | sevoflurane results in decreased phosphorylation of GSK3B protein | CTD | PMID:20807582 |
| simvastatin | increases expression | ISO | RGD:733891 | 6480464 | Simvastatin results in increased expression of GSK3B | CTD | PMID:19461118 |
| simvastatin | multiple interactions | ISO | RGD:70982 | 6480464 | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of GSK3B protein] | CTD | PMID:18047562 |
| simvastatin | increases expression | ISO | RGD:70982 | 6480464 | Simvastatin results in increased expression of GSK3B protein modified form | CTD | PMID:18004065 |
| simvastatin | multiple interactions | ISO | RGD:70982 | 6480464 | Simvastatin inhibits the reaction [Glucose results in decreased phosphorylation of and results in increased activity of GSK3B protein] | CTD | PMID:18004065 |
| sirolimus | multiple interactions | ISO | RGD:733891 | 6480464 | [3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione results in decreased activity of GSK3B protein] inhibits the reaction [Sirolimus results in decreased expression of CCND1 protein]; more ... | CTD | PMID:15753396 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [TSC1 gene mutant form results in decreased phosphorylation of GSK3B protein] | CTD | PMID:18495876 |
| sirolimus | increases activity | ISO | RGD:733891 | 6480464 | Sirolimus results in increased activity of GSK3B protein | CTD | PMID:15753396 |
| sirolimus | multiple interactions | ISO | RGD:733891 | 6480464 | [Sirolimus results in decreased activity of MTOR protein] which results in increased phosphorylation of GSK3B protein | CTD | PMID:17908691 |
| sodium dichromate | decreases expression | EXP | | 6480464 | sodium bichromate results in decreased expression of GSK3B mRNA | CTD | PMID:22155349 |
| streptozocin | multiple interactions | ISO | RGD:733891 | 6480464 | INS inhibits the reaction [Streptozocin results in decreased phosphorylation of GSK3B protein]; more ... | CTD | PMID:19136650 |
| streptozocin | decreases phosphorylation | EXP | | 6480464 | Streptozocin results in decreased phosphorylation of GSK3B protein | CTD | PMID:19136650 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of GSK3B protein | CTD | PMID:19136650 |
| succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GSK3B mRNA | CTD | PMID:21641980 |
| sulindac | decreases phosphorylation | ISO | RGD:733891 | 6480464 | Sulindac results in decreased phosphorylation of GSK3B protein | CTD | PMID:11593435 |
| tacrolimus hydrate | multiple interactions | ISO | RGD:733891 | 6480464 | [GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein] | CTD | PMID:22416070 |
| tacrolimus hydrate | increases phosphorylation | ISO | RGD:733891 | 6480464 | Tacrolimus results in increased phosphorylation of GSK3B protein | CTD | PMID:22416070 |
| tamibarotene | affects expression | ISO | RGD:733891 | 6480464 | Am 80 affects the expression of GSK3B mRNA; more ... | CTD | PMID:15498508 |
| tamoxifen | multiple interactions | ISO | RGD:733891 | 6480464 | Tamoxifen promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3B protein] | CTD | PMID:22046442 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:733891 | 6480464 | tert-Butylhydroperoxide results in increased expression of GSK3B mRNA | CTD | PMID:15336504 |
| testosterone | increases expression | ISO | RGD:733891 | 6480464 | Testosterone results in increased expression of GSK3B mRNA | CTD | PMID:21880219 |
| testosterone enanthate | affects expression | ISO | RGD:733891 | 6480464 | testosterone enanthate affects the expression of GSK3B mRNA | CTD | PMID:17440010 |
| trans-resveratrol | increases expression | ISO | RGD:733891 | 6480464 | resveratrol results in increased expression of GSK3B protein modified form | CTD | PMID:21505870 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of GSK3B protein | CTD | PMID:19665018 |
| trans-resveratrol | decreases activity | EXP | | 6480464 | resveratrol results in decreased activity of GSK3B protein | CTD | PMID:19665018 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose] | CTD | PMID:22180358 |
| trans-resveratrol | multiple interactions | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein]; more ... | CTD | PMID:20696143 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein]; more ... | CTD | PMID:20542495 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:733891 | 6480464 | resveratrol results in increased phosphorylation of GSK3B protein | CTD | PMID:14750165 |
| trans-resveratrol | increases activity | ISO | RGD:733891 | 6480464 | resveratrol results in increased activity of GSK3B protein | CTD | PMID:17868649 PMID:20090934 |
| trans-resveratrol | multiple interactions | ISO | RGD:733891 | 6480464 | [resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSPA1A protein; more ... | CTD | PMID:20090934 |
| trans-resveratrol | decreases phosphorylation | ISO | RGD:733891 | 6480464 | resveratrol results in decreased phosphorylation of GSK3B protein | CTD | PMID:14750165 PMID:20090934 |
| trans-resveratrol | multiple interactions | ISO | RGD:733891 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of GSK3B protein] | CTD | PMID:14750165 |
| trans-resveratrol | decreases expression | ISO | RGD:733891 | 6480464 | resveratrol results in decreased expression of GSK3B protein modified form | CTD | PMID:20133117 PMID:20457218 |
| trans-resveratrol | affects expression | ISO | RGD:733891 | 6480464 | resveratrol affects the expression of GSK3B protein modified form | CTD | PMID:22234583 |
| trans-resveratrol | multiple interactions | ISO | RGD:733891 | 6480464 | ARRB2 protein affects the reaction [resveratrol results in decreased expression of GSK3B protein modified form] | CTD | PMID:20457218 |
| trans-resveratrol | increases phosphorylation | EXP | | 6480464 | resveratrol results in increased phosphorylation of GSK3B protein | CTD | PMID:19665018 PMID:22180358 |
| trans-resveratrol | multiple interactions | ISO | RGD:70982 | 6480464 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [resveratrol results in increased activity of GSK3B protein]; more ... | CTD | PMID:19135050 |
| trans-resveratrol | multiple interactions | ISO | RGD:70982 | 6480464 | resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein | CTD | PMID:16860989 |
| trans-resveratrol | increases activity | ISO | RGD:733891 | 6480464 | resveratrol results in increased activity of GSK3B protein | CTD | PMID:17868649 |
| trans-resveratrol | decreases activity | ISO | RGD:733891 | 6480464 | resveratrol results in decreased activity of GSK3B protein | CTD | PMID:19620254 |
| trans-resveratrol | multiple interactions | ISO | RGD:733891 | 6480464 | resveratrol inhibits the reaction [MFGE8 protein results in decreased expression of GSK3B protein modified form] | CTD | PMID:21505870 |
| trans-resveratrol | multiple interactions | ISO | RGD:733891 | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in decreased activity of GSK3B protein]; more ... | CTD | PMID:19620254 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:733891 | 6480464 | resveratrol results in increased phosphorylation of GSK3B protein | CTD | PMID:14750165 PMID:19620254 |
| troglitazone | multiple interactions | ISO | RGD:733891 | 6480464 | GSK3B protein affects the susceptibility to [troglitazone results in decreased expression of CCNB1 protein]; more ... | CTD | PMID:20540935 |
| troglitazone | decreases activity | ISO | RGD:733891 | 6480464 | troglitazone results in decreased activity of GSK3B protein | CTD | PMID:20540935 |
| troglitazone | affects response to substance | ISO | RGD:733891 | 6480464 | GSK3B protein affects the susceptibility to troglitazone | CTD | PMID:20540935 |
| valproic acid | multiple interactions | ISO | RGD:733891 | 6480464 | Valproic Acid results in increased phosphorylation of and results in decreased activity of GSK3B protein | CTD | PMID:19328817 |
| valproic acid | decreases expression | ISO | RGD:70982 | 6480464 | Valproic Acid results in decreased expression of GSK3B mRNA | CTD | PMID:19359144 |
| valproic acid | increases phosphorylation | ISO | RGD:733891 | 6480464 | Valproic Acid results in increased phosphorylation of GSK3B protein | CTD | PMID:19440698 |
| valproic acid | decreases activity | ISO | RGD:733891 | 6480464 | Valproic Acid results in decreased activity of GSK3B protein | CTD | PMID:19101580 |
| wortmannin | multiple interactions | ISO | RGD:733891 | 6480464 | wortmannin inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein] | CTD | PMID:16076840 |
| wortmannin | decreases phosphorylation | ISO | RGD:733891 | 6480464 | wortmannin results in decreased phosphorylation of GSK3B protein | CTD | PMID:20090934 PMID:23178381 |
| wortmannin | multiple interactions | ISO | RGD:733891 | 6480464 | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of GSK3B protein] | CTD | PMID:17513037 |
| wortmannin | multiple interactions | ISO | RGD:70982 | 6480464 | wortmannin inhibits the reaction [chaetoglobosins results in increased phosphorylation of GSK3B protein] | CTD | PMID:18040759 |
| wortmannin | multiple interactions | ISO | RGD:733891 | 6480464 | wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of GSK3B protein] | CTD | PMID:12614848 |
| wortmannin | decreases phosphorylation | ISO | RGD:733891 | 6480464 | wortmannin results in decreased phosphorylation of GSK3B protein | CTD | PMID:20090934 |
| wortmannin | multiple interactions | ISO | RGD:70982 | 6480464 | wortmannin inhibits the reaction [rosiglitazone results in increased phosphorylation of GSK3B protein] | CTD | PMID:19566839 |
| wortmannin | decreases expression | EXP | | 6480464 | wortmannin results in decreased expression of GSK3B protein modified form | CTD | PMID:15842767 |
| wortmannin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [wortmannin results in decreased expression of GSK3B protein modified form]; more ... | CTD | PMID:15842767 |
| zinc atom | multiple interactions | ISO | RGD:70982 | 6480464 | AKT1 protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of and results in increased activity of GSK3B protein]; more ... | CTD | PMID:17098228 |
| zinc atom | decreases phosphorylation | ISO | RGD:70982 | 6480464 | Zinc deficiency results in decreased phosphorylation of GSK3B protein | CTD | PMID:21893222 |
| zinc atom | increases phosphorylation | ISO | RGD:733891 | 6480464 | Zinc results in increased phosphorylation of GSK3B protein | CTD | PMID:17513037 |
| zinc atom | multiple interactions | ISO | RGD:733891 | 6480464 | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of GSK3B protein]; more ... | CTD | PMID:17513037 |
| zinc(0) | multiple interactions | ISO | RGD:70982 | 6480464 | AKT1 protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of and results in increased activity of GSK3B protein]; more ... | CTD | PMID:17098228 |
| zinc(0) | multiple interactions | ISO | RGD:733891 | 6480464 | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of GSK3B protein]; more ... | CTD | PMID:17513037 |
| zinc(0) | increases phosphorylation | ISO | RGD:733891 | 6480464 | Zinc results in increased phosphorylation of GSK3B protein | CTD | PMID:17513037 |
| zinc(0) | decreases phosphorylation | ISO | RGD:70982 | 6480464 | Zinc deficiency results in decreased phosphorylation of GSK3B protein | CTD | PMID:21893222 |